
Lowell L. Hart, MD, discusses personalized treatment approaches for patients with HER2-positive breast cancer.

Your AI-Trained Oncology Knowledge Connection!


Lowell L. Hart, MD, discusses personalized treatment approaches for patients with HER2-positive breast cancer.

Lowell L. Hart, MD, FACP, scientific director of Clinical Research at Florida Cancer Specialists & Research Institute, and associate professor of Internal Medicine at Wake Forest School of Medicine, discusses the impact of trilaciclib on myelosuppression in patients with previously treated extensive-stage small cell lung cancer.

Lowell L. Hart, MD, scientific director of Research at Florida Cancer Specialists & Research Institute, and associate professor of Internal Medicine at Wake Forest School of Medicine, discusses the recent advances in the area of ALK-positive non–small cell lung cancer.

Published: December 1st 2016 | Updated:

Published: August 30th 2019 | Updated:

Published: January 9th 2020 | Updated: